Lentini Renee 4
4 · ImmunoGen, Inc. · Filed Feb 6, 2024
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
Lentini Renee
V.P.-Fin., Prin. Acctg. Off.
Transactions
- Sale
Common Stock
2024-02-05$29.30/sh−2,631$77,088→ 14,723 total - Exercise/Conversion
Common Stock
2024-02-02+8,435→ 17,354 total - Exercise/Conversion
Restricted Stock Unit
2024-02-02−8,435→ 16,870 totalExercise: $0.00→ Common Stock (8,435 underlying)
Footnotes (3)
- [F1]Effected pursuant to a trading plan adopted on June 6, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
- [F3]The RSUs were granted on 2/3/2023 and vest over a three-year period, with 33 1/3% of the RSUs vesting on each of the first three anniversaries of the date of grant, subject to continued service through each vesting date.